Miller M, Schneider J, Sathyanarayana B K, Toth M V, Marshall G R, Clawson L, Selk L, Kent S B, Wlodawer A
NCI-Frederick Cancer Research Facility, BRI-Basic Research Program, MD 21701.
Science. 1989 Dec 1;246(4934):1149-52. doi: 10.1126/science.2686029.
The structure of a complex between a peptide inhibitor with the sequence N-acetyl-Thr-Ile-Nle-psi[CH2-NH]-Nle-Gln-Arg.amide (Nle, norleucine) with chemically synthesized HIV-1 (human immunodeficiency virus 1) protease was determined at 2.3 A resolution (R factor of 0.176). Despite the symmetric nature of the unliganded enzyme, the asymmetric inhibitor lies in a single orientation and makes extensive interactions at the interface between the two subunits of the homodimeric protein. Compared with the unliganded enzyme, the protein molecule underwent substantial changes, particularly in an extended region corresponding to the "flaps" (residues 35 to 57 in each chain), where backbone movements as large as 7 A are observed.
测定了序列为N-乙酰基-苏氨酸-异亮氨酸-正亮氨酸-ψ[CH₂-NH]-正亮氨酸-谷氨酰胺-精氨酸酰胺(正亮氨酸,即去甲亮氨酸)的肽抑制剂与化学合成的HIV-1(人类免疫缺陷病毒1型)蛋白酶形成的复合物的结构,分辨率为2.3 Å(R因子为0.176)。尽管未结合配体的酶具有对称性,但不对称的抑制剂处于单一取向,并在同二聚体蛋白的两个亚基之间的界面处产生广泛相互作用。与未结合配体的酶相比,蛋白质分子发生了显著变化,特别是在对应于“瓣片”的延伸区域(每条链中的第35至57位残基),在该区域观察到主链移动高达7 Å。